
Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …

Takeda has attempted to settle its hefty damages bill over claims it was hiding cancer risks in its diabetes drug …

A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

